Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6886
Source ID: NCT03815305
Associated Drug: Centella Asiatica Extract
Title: Effect of Centella Asiatica on Xerotic Skin in Diabetes Mellitus Type 2
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Xerosis Cutis|Diabetes Mellitus, Type 2
Interventions: DRUG: Centella Asiatica Extract|DRUG: Topical CA|DRUG: Petroleum jelly
Outcome Measures: Primary: Change in Skin Capacitance, SCap measured in (AU), 1 month (evaluated every 2 weeks)|Change in SOD, Superoxide Dismutase (compared to total protein), 1 month (evaluated every 2 weeks)|Change in IL-1α, Interleukin-1α (compared to total protein), 1 month (evaluated every 2 weeks)|Change in AGEs CML, Advanced Glycation End Product, N-(Carboxymethyl)lysine (compared to total protein), 1 month (evaluated every 2 week)|Change in SRRC, Specified symptom sum score. Measuring dry skin using four variables (scale, roughness, redness, and cracking) in score ranged from 1 to 4 for each variable. The highest the value marks the driest skin, 1 month (evaluated every 2 week) |
Sponsor/Collaborators: Sponsor: Indonesia University
Gender: ALL
Age: CHILD, ADULT
Phases: PHASE4
Enrollment: 159
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2018-07-30
Completion Date: 2019-06-30
Results First Posted:
Last Update Posted: 2019-01-24
Locations: Universitas Indonesia, Jakarta Pusat, Jakarta, 10430, Indonesia
URL: https://clinicaltrials.gov/show/NCT03815305